Invion, Inc.   Report issue

For profit Phase 2
Founded: East Kew Australia (2000)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2007
NCT00670267
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now